GL1X · GenesisL1 explorer

MolNFT v1 · #169424 · protein

Crystal structure of the SARS-cov-2 (COVID-19) main protease in complex with inhibitor UAW247

6XBH · 3C-like proteinase: “Crystal structure of the SARS-cov-2 (COVID-19) main protease in complex with inhibitor UAW247”. X-ray diffraction, 2 ligands (P6S, NA), 2 pockets (best druggability 0.37). MolNFT v1 #169424 on GenesisL1: 3D…

PDB
6XBH
Type
protein
Length
306 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase; Inhibitor UAW247
EC
3.4.22.69
UniProt
P0DTD1
Ligands
P6S, NA
Pockets
2 · best druggability 0.37

Structure

x-ray diffraction · 2 distinct chains · 26% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30426% helix, 28% strandP0DTD1
CInhibitor UAW247protein20% helix, 0% strand—

Ligands and binding sites

  • P6S · benzyl hydrogen carbonate · ligand · chains A, C
  • NA · Sodium ion · metal · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11280.370.7319empty
2600.290.7415empty

Interfaces

1 interface between chains.

  • A–C · 359 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent, 1 modified (covalent ligand, nonstandard).

Compared structures

  • 6XBH · Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.